Testosterone Therapy Does Not Raise Prostate Cancer Recurrence Risk
Testosterone replacement therapy (TRT) does not appear to increase the risk of prostate cancer (PCa) recurrence in men following radical prostatectomy, researchers concluded. Alexander W. Pastuszak, MD, PhD, of the Baylor College of Medicine in Houston, and colleagues reviewed data from 103 hypogonadal PCa patients treated with testosterone after radical prostatectomy (treatment group) and 49 PCa […]
Continue reading →